2.99

0.99% -0.03

After Hours: 3.05 0.06 +2.01%

Prokidney Corp (PROK)

Overview News Price History Option Chain Financials Discussions Forecast

Prokidney Corp stock is traded at $2.99, with a volume of 1.96M. It is down -0.99% in the last 24 hours and up +20.56% over the past month. ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Previous Close:

$3.02

Open:

$3.02

24h Volume:

1.96M

Relative Volume:

0.52

Market Cap:

$403.63M

Revenue:

Net Income/Loss:

$-35.47M

P/E Ratio:

-5.2456

EPS:

-0.57

Net Cash Flow:

$-124.27M

1W Performance:

+3.10%

1M Performance:

+20.56%

6M Performance:

+308.86%

1Y Performance:

+63.39%

1-Day Range:

$2.80

$3.05

1-Week Range:

$2.77

$3.47

52-Week Range:

$0.4603

$7.13

Prokidney Corp Stock (PROK) Company Profile

Name

Prokidney Corp

Sector

Healthcare (1142)

Industry

Biotechnology (639)

Phone

336-999-7028

Address

2000 FRONTIS PLAZA BLVD., WINSTON-SALEM

Employee

204

Twitter

Next Earnings Date

2024-12-09

Latest SEC Filings

PROK's Discussions on Twitter

Compare PROK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PROK Prokidney Corp	2.99	407.68M	0	-35.47M	-124.27M	-0.57
VRTX Vertex Pharmaceuticals Inc	407.37	104.55B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	464.95	60.36B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	557.73	59.84B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	799.56	49.07B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	327.03	35.16B	4.56B	-176.77M	225.30M	-1.7177

Prokidney Corp Stock (PROK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-30-25	Downgrade	BofA Securities	Neutral → Underperform
Sep-30-24	Initiated	JP Morgan	Neutral
Sep-10-24	Initiated	Guggenheim	Buy
Mar-07-24	Resumed	Morgan Stanley	Equal-Weight
Jan-02-24	Downgrade	BofA Securities	Buy → Neutral
Jul-25-23	Initiated	BTIG Research	Buy
Dec-21-22	Initiated	Jefferies	Buy
Nov-10-22	Initiated	Morgan Stanley	Equal-Weight
Oct-18-22	Initiated	UBS	Buy
Oct-14-22	Initiated	Citigroup	Buy
Sep-23-22	Initiated	BofA Securities	Buy
Sep-02-22	Initiated	Evercore ISI	Outperform

View All

Prokidney Corp Stock (PROK) Latest News

12:12 PM

Is ProKidney Corp. stock poised for growthTrade Risk Report & Risk Adjusted Buy and Sell Alerts - newser.com

12:12 PM

11:13 AM

How to monitor ProKidney Corp. with trend dashboardsQuarterly Profit Report & Safe Capital Preservation Plans - newser.com

11:13 AM

09:40 AM

Short interest data insights for ProKidney Corp.Layoff News & Community Consensus Stock Picks - newser.com

09:40 AM

09:17 AM

Heatmap analysis for ProKidney Corp. and competitorsWeekly Investment Summary & AI Optimized Trade Strategies - newser.com

09:17 AM

08:26 AM

Price momentum metrics for ProKidney Corp. explainedWeekly Profit Summary & Consistent Income Trade Ideas - newser.com

08:26 AM

08:19 AM

Risk adjusted return profile for ProKidney Corp. analyzed2025 Sector Review & Smart Investment Allocation Insights - newser.com

08:19 AM

07:26 AM

Discovering Potential: IZEA Worldwide And 2 Other Top Penny Stocks - simplywall.st

07:26 AM

Oct 10, 2025

ProKidney's (PROK) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 10, 2025

Why ProKidney Corp. is moving today2025 Market Overview & Fast Moving Stock Trade Plans - newser.com

Oct 10, 2025

Why ProKidney Corp. stock appeals to dividend seekersJuly 2025 Earnings & Weekly Top Gainers Trade List - newser.com

Oct 10, 2025

Real time pattern detection on ProKidney Corp. stock2025 Winners & Losers & Fast Exit and Entry Strategy Plans - newser.com

Oct 10, 2025

Oct 08, 2025

ProKidney (NASDAQ:PROK) Shares Gap DownWhat's Next? - MarketBeat

Oct 08, 2025

Will ASN Spotlight On REGEN-007 Propel ProKidney Toward Accelerated Approval? - RTTNews

Oct 08, 2025

Oct 06, 2025

Using AI based signals to follow ProKidney Corp.Quarterly Portfolio Report & Advanced Swing Trade Entry Plans - newser.com

Oct 06, 2025

Oct 05, 2025

What institutional flow reveals about ProKidney Corp.Layoff News & Smart Allocation Stock Reports - newser.com

Oct 05, 2025

Smart tools for monitoring ProKidney Corp.’s price actionGap Up & Community Consensus Trade Alerts - newser.com

Oct 05, 2025